{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:37:51Z","timestamp":1782319071326,"version":"3.54.5"},"reference-count":103,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Mucopolysaccharidoses are extremely rare diseases that are frequently presenting with structural heart problems of the aortic and mitral valve in combination with myocardial dysfunction. In a substantial proportion, this leads to heart failure and is a leading cause of death in these patients. As this glycosaminoglycan degradation defect is associated with other conditions strongly influencing the perioperative risk and choice of surgical technique, multidisciplinary planning is crucial to improve short- and long-term outcomes. The extensive variance in clinical presentation between different impaired enzymes, and further within subgroups, calls for personalised treatment plans. Enzyme replacement therapies and bone marrow transplantation carry great potential as they may significantly abrogate the progress of the disease and as such reduce the clinical burden and improve life expectancy. Nevertheless, structural heart interventions may be required. We reviewed the existing literature of the less than 50 published cases regarding surgical management, technique, and choice of prostheses. Although improvement in therapy has shown promising results in protecting valvar tissue when initiated in infancy, concerns regarding stability of this effect and durability of biological prostheses remain.<\/jats:p>","DOI":"10.3390\/biomedicines10020375","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T11:35:17Z","timestamp":1643974517000},"page":"375","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Surgical Management of Valvular Heart Disease in Mucopolysaccharidoses: A Review of Literature"],"prefix":"10.3390","volume":"10","author":[{"given":"Barbara A.","family":"Rosser","sequence":"first","affiliation":[{"name":"Department of Congenital Heart Surgery, Royal Brompton Hospital, London SW3 6NP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Congenital Heart Surgery, Royal Brompton Hospital, London SW3 6NP, UK"},{"name":"Department of Surgery and Cancer, Imperial College London, St. Mary\u2019s Hospital, London W2 1NY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hoschtitzky","sequence":"additional","affiliation":[{"name":"Department of Congenital Heart Surgery, Royal Brompton Hospital, London SW3 6NP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/heartjnl-2015-309258","article-title":"Cardiac issues in adults with the mucopolysaccharidoses: Current knowledge and emerging needs","volume":"102","author":"Braunlin","year":"2016","journal-title":"Heart"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.5582\/irdr.2020.01011","article-title":"A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management","volume":"9","author":"Zhou","year":"2020","journal-title":"Intractable Rare Dis. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ymgme.2017.05.016","article-title":"Epidemiology of mucopolysaccharidoses","volume":"121","author":"Khan","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12902-018-0311-x","article-title":"Short stature as a presenting symptom of attenuated Mucopolysaccharidosis type I: Case report and clinical insights","volume":"18","author":"Martins","year":"2018","journal-title":"BMC Endocr. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lin, S.P., Lin, H.Y., Wang, T.J., Chang, C.Y., Lin, C.H., Huang, S.F., Tsai, C.C., Liu, H.L., Keutzer, J., and Chuang, C.K. (2013). A pilot newborn screening program for Mucopolysaccharidosis type i in Taiwan. Orphanet J. Rare Dis., 8.","DOI":"10.1186\/1750-1172-8-147"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Donati, M.A., Pasquini, E., Spada, M., Polo, G., and Burlina, A. (2018). Newborn screening in mucopolysaccharidoses 11 Medical and Health Sciences 1114 Paediatrics and Reproductive Medicine. Ital. J. Pediatr., 44.","DOI":"10.1186\/s13052-018-0552-3"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejim.2016.05.017","article-title":"Unique medical issues in adult patients with mucopolysaccharidoses","volume":"34","author":"Mitchell","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/ajmg.a.61566","article-title":"Natural history of the oldest known females with mucopolysaccharidosis type IVA (Morquio A syndrome)","volume":"182","author":"Peretz","year":"2020","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/gim.2014.25","article-title":"The natural history of MPS I: Global perspectives from the MPS I Registry","volume":"16","author":"Beck","year":"2014","journal-title":"Genet. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-3-24","article-title":"The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK","volume":"3","author":"Moore","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: Presentation, diagnosis and management","volume":"34","author":"Braunlin","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/GIM.0b013e31817701e6","article-title":"Initial report from the Hunter Outcome Survey","volume":"10","author":"Wraith","year":"2008","journal-title":"Genet. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10545-009-1119-7","article-title":"Mortality and cause of death in mucopolysaccharidosis type II - A historical review based on data from the Hunter Outcome Survey (HOS)","volume":"32","author":"Jones","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajmg.a.33779","article-title":"Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece","volume":"155","author":"Mikaeloff","year":"2011","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13023-017-0717-y","article-title":"Mortality in patients with Sanfilippo syndrome","volume":"12","author":"Lavery","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/ajmg.a.40351","article-title":"Mucopolysaccharidosis III in Taiwan: Natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21-year period","volume":"176","author":"Lin","year":"2018","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","article-title":"International Morquio A Registry: Clinical manifestation and natural course of Morquio A disease","volume":"30","author":"Tomatsu","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_18","first-page":"59","article-title":"Mortality in Patients with Morquio Syndrome A","volume":"15","author":"Lavery","year":"2015","journal-title":"JIMD Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-018-0883-6","article-title":"Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA","volume":"13","author":"Lin","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10545-011-9410-9","article-title":"Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP)","volume":"36","author":"Hendriksz","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-5-5","article-title":"Mucopolysaccharidosis VI","volume":"5","author":"Valayannopoulos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/gim.2017.10","article-title":"Quantitative clinical characteristics of 53 patients with MPS VII: A cross-sectional analysis","volume":"19","author":"Zielonka","year":"2017","journal-title":"Genet. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jmedgenet-2015-103322","article-title":"Clinical course of sly syndrome (mucopolysaccharidosis type VII)","volume":"53","author":"Steiner","year":"2016","journal-title":"J. Med. Genet."},{"key":"ref_24","first-page":"218","article-title":"Localization and pattern of expression of extracellular matrix components in human heart valves","volume":"14","author":"Latif","year":"2005","journal-title":"J. Heart Valve Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1017\/S104795110999062X","article-title":"Echocardiographic study of paediatric patients with mucopolysaccharidosis","volume":"20","author":"Leal","year":"2010","journal-title":"Cardiol. Young"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/01.CIR.21.1.80","article-title":"Mitral stenosis in an atypical case of gargoylism: A case report with pathologic and histochemical studies of the cardiac tissues","volume":"21","author":"Vanace","year":"1960","journal-title":"Circulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF01991908","article-title":"Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses","volume":"154","author":"Wippermann","year":"1995","journal-title":"Eur. J. Pediatr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.carpath.2010.06.004","article-title":"Clear cells in the atrioventricular valves of infants with severe human mucopolysaccharidosis (Hurler syndrome) are activated valvular interstitial cells","volume":"20","author":"Braunlin","year":"2011","journal-title":"Cardiovasc. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/ajmg.a.36105","article-title":"Macrophage involvement in mitral valve pathology in mucopolysaccharidosis type VI (Maroteaux-lamy syndrome)","volume":"161","author":"Brands","year":"2013","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s004310050872","article-title":"Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders- clinical and echocardiographic findings in 64 patients","volume":"157","author":"Dangel","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"117R","DOI":"10.1093\/glycob\/cwf066","article-title":"Dermatan sulfate: New functions from an old glycosaminoglycan","volume":"12","author":"Trowbridge","year":"2002","journal-title":"Glycobiology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1651-2227.2002.tb03330.x","article-title":"Cardiovascular changes in children with mucopolysaccharide disorders","volume":"91","author":"Mohan","year":"2002","journal-title":"Acta Paediatr. Int. J. Paediatr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10545-010-9113-7","article-title":"Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis i","volume":"33","author":"Thomas","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1651-2227.2007.00212.x","article-title":"A clinical study of 77 patients with mucopolysaccharidosis type II","volume":"96","author":"Schwartz","year":"2007","journal-title":"Acta Paediatr. Int. J. Paediatr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.01.021","article-title":"The Morquio A Clinical Assessment Program: Baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects","volume":"109","author":"Harmatz","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10545-013-9649-4","article-title":"Mucopolysaccharidosis VI: Cardiac involvement and the impact of enzyme replacement therapy","volume":"37","author":"Kampmann","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_37","unstructured":"(2016). Meena Bolourchi,1,2 Pierangelo Renella,1,2,3 and Raymond Y. Wang2,4,* Aortic Root Dilatation in Mucopolysaccharidosis I\u2013VII. Int. J. Mol. Sci., 17."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.carpath.2015.06.001","article-title":"Cardiovascular pathologies in mucopolysaccharidosis type VII (Sly Syndrome)","volume":"24","author":"Gniadek","year":"2015","journal-title":"Cardiovasc. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.carpath.2014.01.001","article-title":"Unexpected coronary artery findings in mucopolysaccharidosis. Report of four cases and literature review","volume":"23","author":"Braunlin","year":"2014","journal-title":"Cardiovasc. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13052-018-0560-3","article-title":"Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: A practical guide for paediatric and adult cardiologists 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology","volume":"44","author":"Boffi","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","article-title":"Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future","volume":"25","author":"Taylor","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Sawamoto, K., Stapleton, M., Alm\u00e9ciga-D\u00edaz, C.J., Espejo-Mojica, A.J., Losada, J.C., Suarez, D.A., and Tomatsu, S. (2019). Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments, Springer International Publishing.","DOI":"10.1007\/s40265-019-01147-4"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","article-title":"Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: An international multicenter study","volume":"125","author":"Aldenhoven","year":"2015","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13052-018-0562-1","article-title":"Enzyme replacement therapy: Efficacy and limitations","volume":"44","author":"Concolino","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jpeds.2016.08.033","article-title":"Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I","volume":"178","author":"Laraway","year":"2016","journal-title":"J. Pediatr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study","volume":"148","author":"Harmatz","year":"2006","journal-title":"J. Pediatr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"232640981875580","DOI":"10.1177\/2326409818755800","article-title":"Long-Term Galsulfase Treatment Associated With Improved Survival of Patients With Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome)","volume":"6","author":"Quartel","year":"2018","journal-title":"J. Inborn Errors Metab. Screen."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10545-012-9481-2","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI: Long-term cardiac effects of galsulfase (Naglazyme\u00ae) therapy","volume":"36","author":"Braunlin","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e0184065","DOI":"10.1371\/journal.pone.0184065","article-title":"Efficacy and safety of intravenous laronidase for mucopolysaccharidosis type I: A systematic review and meta-analysis","volume":"12","author":"Dornelles","year":"2017","journal-title":"PLoS ONE"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-8-51","article-title":"Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase","volume":"8","author":"Brands","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ymgme.2019.07.016","article-title":"Ten years of enzyme replacement therapy in paediatric onset mucopolysaccharidosis II in England","volume":"129","author":"Broomfield","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ymgme.2021.03.006","article-title":"Long-term outcomes of patients with mucopolysaccharidosis VI treated with galsulfase enzyme replacement therapy since infancy","volume":"133","author":"Garcia","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgmr.2015.09.002","article-title":"Mucopolysaccharidosis type VI on enzyme replacement therapy since infancy: Six years follow-up of four children","volume":"5","author":"Horovitz","year":"2015","journal-title":"Mol. Genet. Metab. Reports"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1399-0004.2009.01324.x","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age-a sibling control study","volume":"77","author":"McGill","year":"2010","journal-title":"Clin. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgmr.2015.10.014","article-title":"Residual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6 years of enzyme replacement therapy: Implications for early diagnosis and therapy","volume":"5","author":"Sato","year":"2015","journal-title":"Mol. Genet. Metab. Reports"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/0218492316675533","article-title":"Maroteaux-Lamy syndrome: A rare and challenging case of mitral valve replacement","volume":"26","author":"Bell","year":"2018","journal-title":"Asian Cardiovasc. Thorac. Ann."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.athoracsur.2015.11.062","article-title":"Aortic and Mitral Valve Involvement in Maroteaux-Lamy Syndrome VI: Surgical Implications in the Enzyme Replacement Therapy Era","volume":"102","author":"Torre","year":"2016","journal-title":"Ann. Thorac. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10545-012-9563-1","article-title":"Anaesthesia and airway management in mucopolysaccharidosis","volume":"36","author":"Walker","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jpedsurg.2011.09.042","article-title":"High rate of postoperative mortality in patients with mucopolysaccharidosis I: Findings from the MPS i Registry","volume":"47","author":"Arn","year":"2012","journal-title":"J. Pediatr. Surg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1365-2044.1994.tb04360.x","article-title":"Anaesthesia and mucopolysaccharidoses: A review of airway problems in children","volume":"49","author":"WALKER","year":"1994","journal-title":"Anaesthesia"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2253-10-2","article-title":"Anaesthetic considerations of adults with Morquio\u2019s syndrome\u2014A case report","volume":"10","author":"McLaughlin","year":"2010","journal-title":"BMC Anesthesiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1034\/j.1600-0455.2002.430108.x","article-title":"Airway changes in children with mucopolysaccharidoses: CT evaluation","volume":"43","author":"Shih","year":"2002","journal-title":"Acta radiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1053\/j.jvca.2008.12.009","article-title":"Perioperative Implications of Morquio Syndrome in a 31-Year-Old Woman Undergoing Aortic Valve Replacement","volume":"23","author":"Pagel","year":"2009","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF03020496","article-title":"Tracheal intubation in children with Morquio syndrome using the angulated video-intubation laryngoscope","volume":"49","author":"Dullenkopf","year":"2002","journal-title":"Can. J. Anesth."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.athoracsur.2007.03.042","article-title":"Surgical Treatment for Mitral Stenosis in Scheie\u2019s Syndrome: Mucopolysaccharidosis Type I-S","volume":"84","author":"Kitabayashi","year":"2007","journal-title":"Ann. Thorac. Surg."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.athoracsur.2011.03.051","article-title":"Double-valve replacement for scheie\u2019s syndrome subtype mucopolysaccaridosis type 1-S","volume":"92","author":"Murashita","year":"2011","journal-title":"Ann. Thorac. Surg."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(07)60526-1","article-title":"12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: A randomised double-blind trial","volume":"369","author":"Bellissant","year":"2007","journal-title":"Lancet"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Brazier, A., Hasan, R., Jenkins, P., and Hoschtitzky, A. (2015). Urgent resection of a giant left atrial appendage aneurysm and mitral valve replacement in a complex case of Hurler-Scheie syndrome. BMJ Case Rep., 2015.","DOI":"10.1136\/bcr-2015-211551"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.athoracsur.2004.06.033","article-title":"Calcification of tissue heart valve substitutes: Progress toward understanding and prevention","volume":"79","author":"Schoen","year":"2005","journal-title":"Ann. Thorac. Surg."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.carpath.2018.04.001","article-title":"Late diagnosis of mucopolysaccharidosis type IVB and successful aortic valve replacement in a 60-year-old female patient","volume":"35","author":"Dostalova","year":"2018","journal-title":"Cardiovasc. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/CIR.0000000000000029","article-title":"2014 AHA\/ACC Guideline for the Management of Patients with Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Nishimura","year":"2014","journal-title":"Circulation"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"NP22","DOI":"10.1177\/2150135117690105","article-title":"Mucopolysaccharidoses Causing Valvular Heart Disease: Report and Review of Surgical Management","volume":"11","author":"Encarnacion","year":"2020","journal-title":"World J. Pediatr. Congenit. Hear. Surg."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Manna, R., Graziani, F., Lillo, R., Verrecchia, E., Sicignano, L.L., and Rigante, D. (2021). An uplifted destiny for mucopolysaccharidosis type I with heart valve involvement. Intern. Emerg. Med., 21\u201322.","DOI":"10.1007\/s11739-021-02746-4"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1253\/jcj.62.700","article-title":"Surgical treatment for Scheie\u2019s syndrome (mucopolysaccharidosis type I- S): Report of two cases","volume":"62","author":"Minakata","year":"1998","journal-title":"Jpn. Circ. J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.athoracsur.2004.06.021","article-title":"Mitral valve replacement for mitral stenosis secondary to Hunter\u2019s syndrome","volume":"80","author":"Bhattacharya","year":"2005","journal-title":"Ann. Thorac. Surg."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/01.CIR.85.1.188","article-title":"Valvular heart disease in four patients with Maroteaux-Lamy syndrome","volume":"85","author":"Tan","year":"1992","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7326\/0003-4819-92-4-496","article-title":"Aortic stenosis and mucopolysaccharidosis","volume":"92","author":"Wilson","year":"1980","journal-title":"Ann. Intern. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.optechstcvs.2016.02.005","article-title":"The Konno-Rastan Procedure for Anterior Aortic Annular Enlargement","volume":"20","author":"Roeser","year":"2015","journal-title":"Oper. Tech. Thorac. Cardiovasc. Surg."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jtcvs.2007.01.097","article-title":"Aortic root enlargement: What are the operative risks?","volume":"134","author":"Dhareshwar","year":"2007","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e004748","DOI":"10.1161\/CIRCOUTCOMES.118.004748","article-title":"The Ross Procedure: A Systematic Review, Meta-Analysis, and Microsimulation","volume":"11","author":"Etnel","year":"2018","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1016\/j.athoracsur.2019.03.011","article-title":"Visual Loss Post Ross Procedure in an Adolescent With Newly Diagnosed Mucopolysaccharidosis Type II","volume":"108","author":"Curran","year":"2019","journal-title":"Ann. Thorac. Surg."},{"key":"ref_82","first-page":"839","article-title":"Morquio\u2019s syndrome: Severe aortic regurgitation and late pulmonary autograft failure","volume":"15","author":"Barry","year":"2006","journal-title":"J. Heart Valve Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1910555","article-title":"Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement","volume":"382","author":"Makkar","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","article-title":"5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): A randomised controlled trial","volume":"385","author":"Mack","year":"2015","journal-title":"Lancet"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1016\/j.ijcard.2013.12.233","article-title":"Management of aortic stenosis in mucopolysaccharidosis type i","volume":"172","author":"Felice","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.xjtc.2020.06.018","article-title":"Redo surgery after transcatheter aortic valve replacement with a balloon-expandable valve","volume":"3","author":"Nakazato","year":"2020","journal-title":"JTCVS Tech."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/hrt.2005.067363","article-title":"Prosthesis-patient mismatch: Definition, clinical impact, and prevention","volume":"92","author":"Pibarot","year":"2006","journal-title":"Heart"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/CIRCULATIONAHA.108.778886","article-title":"Prosthetic heart valves: Selection of the optimal prosthesis and long-term management","volume":"119","author":"Pibarot","year":"2009","journal-title":"Circulation"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0022-5223(19)37667-6","article-title":"Enlargement of mitral valvular ring. New technique for double valve replacement in children or adults with small mitral anulus","volume":"81","author":"Rastan","year":"1981","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF00796996","article-title":"Severe mitral insufficiency in mucopolysaccharidosis type III-B (Sanfilippo syndrome)","volume":"14","author":"Muenzer","year":"1993","journal-title":"Pediatr Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1378\/chest.103.3.968","article-title":"Aortic stenosis associated with Scheie\u2019s syndrome: Report of successful valve replacement","volume":"103","author":"Masuda","year":"1993","journal-title":"Chest"},{"key":"ref_92","first-page":"214","article-title":"Combined aortic and mitral valve replacement in a child with mucopolysaccharidosis type I: A case report","volume":"18","author":"Goksel","year":"2009","journal-title":"J. Heart Valve Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.amjcard.2017.08.001","article-title":"Outcome of Combined Mitral and Aortic Valve Replacement in Adults With Mucopolysaccharidosis (the Hurler Syndrome)","volume":"120","author":"Robinson","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejcts.2011.06.013","article-title":"Valve surgery in a mucopolysaccharidosis type i patient: Early prosthetic valve endocarditis","volume":"41","author":"Rocha","year":"2012","journal-title":"Eur. J. Cardio-thoracic Surg."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1378\/chest.96.1.209","article-title":"Combined aortic and mitral valve replacement in an adult with Scheie\u2019s disease","volume":"96","author":"Butman","year":"1989","journal-title":"Chest"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1253\/circj.CJ-17-0387","article-title":"Severe aortic and mitral stenosis secondary to slowly progressive hunter syndrome in an elderly patient","volume":"82","author":"Takahashi","year":"2018","journal-title":"Circ. J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13019-021-01530-x","article-title":"Double valve replacement in a patient with Maroteaux \u2013 Lamy syndrome as an ultimate team challenge","volume":"16","author":"Demis","year":"2021","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02559995","article-title":"Combined aortic and mitral valve replacement in an adult with mucopolysaccharidosis (Maroteaux-Lamy syndrome)","volume":"11","author":"Hachida","year":"1996","journal-title":"Heart Vessels"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"107297","DOI":"10.1016\/j.carpath.2020.107297","article-title":"Combined valve replacement and aortocoronary bypass in an adult mucopolysaccharidosis type VII patient","volume":"50","author":"Marek","year":"2021","journal-title":"Cardiovasc. Pathol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/hrt.81.1.97","article-title":"Combined aortic and mitral stenosis in mucopolysaccharidosis type I-S (Ullrich-Scheie syndrome)","volume":"81","author":"Fischer","year":"1999","journal-title":"Heart"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.113.001688","article-title":"Severe mitral stenosis secondary to hunter\u2019s syndrome","volume":"128","author":"Lee","year":"2013","journal-title":"Circulation"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ymgmr.2014.09.003","article-title":"Cardiac disease as the presenting feature of mucopolysaccharidosis type IIIA: A case report","volume":"1","author":"Ribeiro","year":"2014","journal-title":"Mol. Genet. Metab. Reports"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/pgmj.68.798.287","article-title":"Mitral stenosis in the Maroteaux-Lamy syndrome: A treatable cause of dyspnoea","volume":"68","author":"Marwick","year":"1992","journal-title":"Postgrad. Med. J."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/2\/375\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:14:05Z","timestamp":1760134445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/2\/375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":103,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["biomedicines10020375"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10020375","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,4]]}}}